← All trials
NCT00503516
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2007
- Primary completion
- Dec 1, 2009
- Completion date
- Feb 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 39
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- RottapharmLead sponsor
- Universidad Autonoma de BarcelonaOverall official - principal investigator
- Hospital Virgen del Valle (Toledo)Overall official - principal investigator
- Hospital Universitario de GetafeOverall official - principal investigator
- Hospital de la Santa Creu, TortosaOverall official - principal investigator
- Badalona Hospital Germans Trias i PujolOverall official - principal investigator
- Centre d'Atenció Primaria Bon PastorOverall official - principal investigator
- University of BarcelonaStudy chair
- Hospital Sta. Caterina GeronaOverall official - principal investigator
- Antic Hospital Sant Jaume i Santa MagdalenaOverall official - principal investigator
- Rovira i Virgili UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.